6998 — Edding Genor group Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapValue Trap

Annual income statement for Edding Genor group, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0	15.9	0	2,546	2,487
Cost of Revenue
Gross Profit	0	14.9	0	1,716	1,695
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	859	799	711	1,809	1,853
Operating Profit	-859	-783	-711	737	635
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-866	-732	-677	482	496
Provision for Income Taxes
Net Income After Taxes	-865	-730	-675	388	399
Minority Interest
Net Income Before Extraordinary Items
Net Income	-865	-730	-674	388	399
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-865	-730	-674	388	399
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1.75	-1.45	-1.23	0.234	0.239